# Hemoadsorption With CytoSorb® in Post-Cardiac Arrest Syndrome

> **NCT03523039** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 21 (actual)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DEVICE:** CytoSorb® Hemoadsorption

## Key facts

- **NCT ID:** NCT03523039
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-18
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523039, "Hemoadsorption With CytoSorb® in Post-Cardiac Arrest Syndrome". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT03523039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*